OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Role of IL-23 Inhibitors in Crohn’s Disease
Jacopo Fanizza, Ferdinando D’Amico, Francesca Lusetti, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 224-224
Open Access | Times Cited: 14
Jacopo Fanizza, Ferdinando D’Amico, Francesca Lusetti, et al.
Journal of Clinical Medicine (2023) Vol. 13, Iss. 1, pp. 224-224
Open Access | Times Cited: 14
Showing 14 citing articles:
Immunity in digestive diseases: new drugs for inflammatory bowel disease treatment—insights from Phase II and III trials
Sara Massironi, Federica Furfaro, Sarah Bencardino, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 761-787
Open Access | Times Cited: 7
Sara Massironi, Federica Furfaro, Sarah Bencardino, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 9, pp. 761-787
Open Access | Times Cited: 7
Therapeutic potential of mesenchymal stem cell‐derived extracellular vesicles: A focus on inflammatory bowel disease
L Clua-Ferré, R Suau, Irene Vañó‐Segarra, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 6
L Clua-Ferré, R Suau, Irene Vañó‐Segarra, et al.
Clinical and Translational Medicine (2024) Vol. 14, Iss. 11
Open Access | Times Cited: 6
Type 17 immunity: novel insights into intestinal homeostasis and autoimmune pathogenesis driven by gut-primed T cells
Daiya Ohara, Yusuke Takeuchi, Keiji Hirota
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1183-1200
Open Access | Times Cited: 5
Daiya Ohara, Yusuke Takeuchi, Keiji Hirota
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 11, pp. 1183-1200
Open Access | Times Cited: 5
Drug Development in Inflammatory Bowel Diseases: What Is Next?
Lorenzo Petronio, Arianna Dal Buono, Roberto Gabbiadini, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 190-190
Open Access
Lorenzo Petronio, Arianna Dal Buono, Roberto Gabbiadini, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 2, pp. 190-190
Open Access
Inflammatory Bowel Disease in Children: Current Diagnosis and Treatment Strategies
Akshita Bhalla, Aakash Shahi, Madhurima Maity, et al.
Cureus (2025)
Open Access
Akshita Bhalla, Aakash Shahi, Madhurima Maity, et al.
Cureus (2025)
Open Access
The Expanding Therapeutic Potential of Deucravacitinib Beyond Psoriasis: A Narrative Review
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
Chul Hwan Bang, Chul Jong Park, Yoon‐Seob Kim
Journal of Clinical Medicine (2025) Vol. 14, Iss. 5, pp. 1745-1745
Open Access
Comparative Efficacy of Subcutaneous Versus Intravenous Interleukin 12/23 Inhibitors for the Remission of Moderate to Severe Crohn’s Disease: A Systematic Review and Meta-Analysis
Nouran Alwisi, Rana Ismail, Hissa Al-Kuwari, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 702-702
Open Access
Nouran Alwisi, Rana Ismail, Hissa Al-Kuwari, et al.
Biomedicines (2025) Vol. 13, Iss. 3, pp. 702-702
Open Access
New Interleukin-23 Antagonists’ Use in Crohn’s Disease
Laura Biskup, Jan Semeradt, Jagoda Rogowska, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 447-447
Open Access
Laura Biskup, Jan Semeradt, Jagoda Rogowska, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 4, pp. 447-447
Open Access
Advances in the research of intestinal fungi in Crohn's disease
Mo-Wei Kong, Yu Yang, Peng Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4318-4323
Closed Access | Times Cited: 1
Mo-Wei Kong, Yu Yang, Peng Wang, et al.
World Journal of Gastroenterology (2024) Vol. 30, Iss. 39, pp. 4318-4323
Closed Access | Times Cited: 1
La interleucina 23, una citocina relacionada con el tratamiento de la enfermedad inflamatoria intestinal y de otras enfermedades inmunomediadas
Rebeca Pérez‐Cabeza de Vaca, Victor Baylon-Valdez, Uriel Rodríguez-Domínguez, et al.
Revista mexicana de enfermedades inflamatorias inmunomediadas (2024) Vol. 4, Iss. 1
Open Access
Rebeca Pérez‐Cabeza de Vaca, Victor Baylon-Valdez, Uriel Rodríguez-Domínguez, et al.
Revista mexicana de enfermedades inflamatorias inmunomediadas (2024) Vol. 4, Iss. 1
Open Access
Ethnopharmacology, genetic diversity, phytochemistry and pharmacological effects of Panax vietnamensis Ha et Grushv.: A review
Tran Hoang Ngau, Chau Phan Kim Dieu, Chau Phan Kim Hue, et al.
Journal of Environmental Pathology Toxicology and Oncology (2024) Vol. 44, Iss. 1, pp. 73-92
Closed Access
Tran Hoang Ngau, Chau Phan Kim Dieu, Chau Phan Kim Hue, et al.
Journal of Environmental Pathology Toxicology and Oncology (2024) Vol. 44, Iss. 1, pp. 73-92
Closed Access
The Current Status and Prospects of the Application of Mirikizumab in Inflammatory Bowel Disease
远寿 马
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 557-561
Closed Access
远寿 马
Advances in Clinical Medicine (2024) Vol. 14, Iss. 06, pp. 557-561
Closed Access
Safety and Pharmacokinetics of Single‐Dose Mirikizumab in Chinese Healthy Participants: Results From a Phase 1 Study
Junyu Xu, Ran Xie, Yongjia Ji, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 10, pp. 1143-1150
Closed Access
Junyu Xu, Ran Xie, Yongjia Ji, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 10, pp. 1143-1150
Closed Access
Genetic factors that predict response and failure of biologic therapy in inflammatory bowel disease
Milena Peruhova, D. Stoyanova, Dimitrina Georgieva Miteva, et al.
World Journal of Experimental Medicine (2024) Vol. 15, Iss. 1
Closed Access
Milena Peruhova, D. Stoyanova, Dimitrina Georgieva Miteva, et al.
World Journal of Experimental Medicine (2024) Vol. 15, Iss. 1
Closed Access
